Dynavax Technologies Corp. DVAX

NAS: DVAX | ISIN: US2681582019   30/04/2025
11,75 USD (+1,73%)
(+1,73%)   30/04/2025

1 mei 2025 · Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits · Persbericht

29 april 2025 · Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy · Persbericht

22 april 2025 · Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 · Persbericht

17 april 2025 · Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders · Persbericht

3 april 2025 · Dynavax Files Preliminary Proxy Statement · Persbericht

6 maart 2025 · Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase · Persbericht

6 augustus 2024 · Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates · Persbericht

23 juli 2024 · Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 · Persbericht

27 juni 2024 · Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program · Persbericht

28 mei 2024 · Dynavax to Present at Upcoming Investor Conferences · Persbericht

14 mei 2024 · Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S. · Persbericht

8 mei 2024 · Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates · Persbericht

24 april 2024 · Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 · Persbericht

28 februari 2024 · Dynavax to Present at TD Cowen's 44th Annual Health Care Conference · Persbericht

22 februari 2024 · Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance · Persbericht

8 februari 2024 · Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024 · Persbericht

8 januari 2024 · Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights · Persbericht

4 januari 2024 · Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

2 november 2023 · Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance · Persbericht

26 oktober 2023 · Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023 · Persbericht

Mijn selecties